| Mr Tyler Deruyter Brassard, MS | |
|
1 Arch Pl, Greenfield, MA 01301-2457 | |
| (413) 774-1000 | |
| Not Available |
| Full Name | Mr Tyler Deruyter Brassard |
|---|---|
| Gender | Male |
| Speciality | Counselor |
| Location | 1 Arch Pl, Greenfield, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033692413 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Tyler Deruyter Brassard, MS 1 Arch Pl, Greenfield, MA 01301-2457 Ph: (413) 774-1000 | Mr Tyler Deruyter Brassard, MS 1 Arch Pl, Greenfield, MA 01301-2457 Ph: (413) 774-1000 |
News Archive
This fall the CDC estimates that upwards of 50 percent of Americans could come down with the H1N1 virus, killing as many as 1.2 million people. Additionally, there are estimates that many companies will experience between 30-50 percent absenteeism due to employee illness.
Changes "aimed at increasing the agency's efficiency and making it more user-friendly" include combining "the work of the malaria branch, the epidemiology program and HIV/AIDS efforts" under the newly formed Center for Global Health, the Atlanta Journal-Constitution reports (Poole, 1/1).
Studies have shown associations between exposure to traffic-related air pollution and adverse health outcomes, including preterm birth and low birthweight. However, few studies have estimated real-world exposures during personal vehicle trips for women commuters.
A team led by researchers at the National Institutes of Health is the first to systematically survey the landscape of the melanoma genome, the DNA code of the deadliest form of skin cancer. The researchers have made surprising new discoveries using whole-exome sequencing, an approach that decodes the 1-2 percent of the genome that contains protein-coding genes.
CardioVascular BioTherapeutics, Inc. today announced it has submitted an application to the U.S. FDA to obtain "fast track" designation for CVBT-141B, its biological therapy to treat ischemic diabetic wounds based on the active ingredient fibroblast growth factor-1 (FGF-1).
› Verified 2 days ago
Dr. Deauna Venise Webb, PSY.D Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Arch Pl, Greenfield, MA 01301 Phone: 413-774-1000 | |
Kimberly J Lord, BSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Arch Pl, Greenfield, MA 01301 Phone: 413-774-1000 | |
Keagan Paine Wells, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Arch Pl, Greenfield, MA 01301 Phone: 413-774-1000 Fax: 413-774-1776 | |
Ms. Heather Kuhn, MA, R-DMT, RSMT Counselor Medicare: Not Enrolled in Medicare Practice Location: 28 High St, Greenfield, MA 01301 Phone: 508-523-9429 | |
Sophie Lazu, Counselor Medicare: Not Enrolled in Medicare Practice Location: 298 Federal St # Condob3, Greenfield, MA 01301 Phone: 413-774-5411 | |
Ms. Emily Ann Dube, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 107 Conway St, Greenfield, MA 01301 Phone: 413-774-2195 Fax: 413-774-2194 | |
Julia Alexander, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1 Arch Pl, Greenfield, MA 01301 Phone: 413-774-1000 |